Fox NewsFDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’4 hours agoAmy McGorryBy Amy McGorrymore_vert
MD MagazineBeyond Current Standards: Emerging Therapies for Primary Biliary Cholangitis3 days agomore_vert
MD MagazineUpdates in Therapeutic Approaches to PBC Following Elafibranor Approval3 days agomore_vert
STATTop FDA official Peter Marks overruled staff to approve Sarepta gene therapy11 hours agoJason Mast & Matthew HerperBy Jason Mast & Matthew Herpermore_vert
CNBCSarepta stock surges nearly 40% as investors cheer expanded use of gene therapy for Duchenne muscular dystrophy16 hours agomore_vert
Barron'sSarepta Stock Surges on Expanded Approval for Elevidys. What Wall Street Thinks.33 minutes agoJosh Nathan-kazis & Emily DattiloBy Josh Nathan-kazis & Emily Dattilomore_vert
CNNFDA expands approval of first gene therapy for rare form of muscular dystrophy16 hours agoJacqueline HowardBy Jacqueline Howardmore_vert
MarketWatchSarepta’s stock soars 38% after FDA expands approval for DMD drug3 hours agociara linnane & Eleanor LaiseBy ciara linnane & Eleanor Laisemore_vert
USA TODAYDollar Tree failed to remove lead-tainted applesauce pouches, FDA says17 hours agoJames PowelBy James Powelmore_vert
NewsweekApplesauce Recall Investigation Sparks New Warning3 days agoAila SliscoBy Aila Sliscomore_vert
AxiosDollar Tree failed to remove recalled applesauce: FDA2 days agoSareen HabeshianBy Sareen Habeshianmore_vert
The Associated PressDollar Tree left lead-tainted applesauce pouches on store shelves for weeks after recall, FDA says3 days agoJoNel AlecciaBy JoNel Alecciamore_vert
Yahoo LifeWanaBana recall update: FDA sends warning letter to Dollar Tree over lead-contaminated cinnamon apple fruit puree3 days agoNatalie RahhalBy Natalie Rahhalmore_vert
MLive.comIllness linked to edibles prompts FDA investigationYesterdayJustin P. HicksBy Justin P. Hicksmore_vert
FOX 10 News PhoenixArizona health officials, FDA report illnesses linked to Diamond Shruumz candy, chocolate, gummies2 days agoBrent CorradoBy Brent Corradomore_vert
WDIV ClickOnDetroitFDA warns Michigan residents not to eat Diamond Shruumz products after reported illnesses3 days agoBrandon CarrBy Brandon Carrmore_vert
WJRTMichigan health officials warn against eating Diamond Shruumz2 days agoDejanay BoothBy Dejanay Boothmore_vert
BBC.comFDA advisors voted against MDMA therapy – researchers are still fighting for it14 hours agoRachel NuwerBy Rachel Nuwermore_vert
Vox.comThe biggest unknown in psychedelic therapy is not the psychedelics2 days agoSigal SamuelBy Sigal Samuelmore_vert
The Atlanta Journal ConstitutionA.M. ATL: Ecstasy, magic mushrooms and medicine4 days agoTyler EstepBy Tyler Estepmore_vert
The Union LeaderEmory researchers studying psychedelic-assisted treatment for PTSD3 days agoJeremy RedmonBy Jeremy Redmonmore_vert
NewsweekChocolate Recall Update as FDA Sets Risk Level2 days agoAliss HighamBy Aliss Highammore_vertFull Coverage of this story
ReasonIf Opiates Are Killing Americans, Why Won't the FDA Let Us Try an Alternative?18 hours agoJeffrey Singer & Josh BloomBy Jeffrey Singer & Josh Bloommore_vertFull Coverage of this story
NewsweekFDA Escapes Accountability for Removing Abortion Drug Safeguards—for NowOpinion18 hours agoErin Morrow HawleyBy Erin Morrow Hawleymore_vert
SlateThe SCOTUS abortion pill case taught women how to access mifepristone.3 days agoCarrie N. BakerBy Carrie N. Bakermore_vert
ABC NewsA Supreme Court abortion ruling that voters will be happy about7 days agoNathaniel Rakich & Kaleigh RogersBy Nathaniel Rakich & Kaleigh Rogersmore_vert
ReutersJustice Clarence Thomas casts cloud over lawsuits challenging diversity programs4 days agoAlison FrankelBy Alison Frankelmore_vert
The HillSupreme Court abortion pill decision ties issue to Trump-Biden raceYesterdayNathaniel WeixelBy Nathaniel Weixelmore_vert
FiercePharmaNo sweat for dermatology specialist Botanix as hyperhidrosis gel Sofdra gains FDA approval17 hours agoZoey BeckerBy Zoey Beckermore_vert
MSNGuess which high-flying ASX All Ords stock was just halted ahead of a key FDA decision3 days agoBernd StrubenBy Bernd Strubenmore_vert
Pharmacy TimesFDA Approves Sofpironium, First Treatment for Primary axillary Hyperhidrosis20 hours agoAislinn AntrimBy Aislinn Antrimmore_vert
FDA.govConsiderations in Demonstrating Interchangeability With a Reference Product: Update2 days agomore_vert
Managed Healthcare ExecutiveFDA Drafts Rules for Fair Biosimilar Promotion10 days agoTony HagenBy Tony Hagenmore_vert
BioPharm InternationalReviewing the Importance of Biosimilarity and Interchangeability16 days agoFeliza MirasolBy Feliza Mirasolmore_vert
Medpage TodayFDA Plans to Ease Requirements for Biosimilars' Interchangeable Status11 hours agoIan IngramBy Ian Ingrammore_vert
ReutersUS FDA puts Zentalis' cancer drug studies on partial hold after patient deaths3 days agoShailesh Kuber & Mariam E SunnyBy Shailesh Kuber & Mariam E Sunnymore_vert
Fierce BiotechZentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths3 days agoJames WaldronBy James Waldronmore_vert
GlobeNewswireZentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program3 days agomore_vert
BioSpaceZentalis Hit With FDA Partial Clinical Hold on Cancer Studies After Patient Deaths3 days agoKate GoodwinBy Kate Goodwinmore_vert
PR NewswireJohnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of moderately to severely active Crohn's disease18 hours agomore_vert
FiercePharmaJ&J's subcutaneous version of Tremfya excels in Crohn's disease studyYesterdayKevin DunleavyBy Kevin Dunleavymore_vert
NewswiseStudy led by UChicago Medicine physician finds new treatment for ulcerative colitis4 days agomore_vert
HMP Global Learning NetworkRemo Panaccione, MD, on the GALAXI Trials of Guselkumab4 days agomore_vert
MorningstarJohnson & Johnson Sees Positive Trial Results for TremfyaYesterdayChris WackBy Chris Wackmore_vert
BBC.comContinuous glucose monitors on the rise after FDA approval6 days agoHolly HonderichBy Holly Honderichmore_vert
The VergeAbbott gets FDA clearance for over-the-counter continuous glucose monitors11 days agoVictoria SongBy Victoria Songmore_vert
CNBCFDA approves two new Abbott over-the-counter continuous glucose monitors11 days agoAshley CapootBy Ashley Capootmore_vert
MD MagazineDiabetes Dialogue: June 2024 Updates in Diabetes Tech and Type 1 Diabetes4 days agoDiana Isaacs & Natalie BelliniBy Diana Isaacs & Natalie Bellinimore_vert
ReutersUS FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug4 days agoSriparna Roy & Krishna Chandra EluriBy Sriparna Roy & Krishna Chandra Elurimore_vertFull Coverage of this story
Food Safety NewsCottage cheese is getting a pass on the FDA's food traceability rule2 days agomore_vert
Quality Assurance & Food SafetyFDA Proposes to Exempt Certain Cottage Cheese from Traceability Requirements4 days agoJackie MitchellBy Jackie Mitchellmore_vert
RFD-TVSome traceability changes for certain cottage cheeses may soon be in the works3 days agoCurrey McCulloughBy Currey McCulloughmore_vert
Yahoo FinancePharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs1 hour agoKinjel ShahBy Kinjel Shahmore_vert
American Medical AssociationAfter false start, FDA drags its feet on menthol cigarette ban3 hours agoTanya Albert HenryBy Tanya Albert Henrymore_vert
FiercePharmaBristol Myers bags FDA tumor-agnostic nod for Augtyro to challenge Bayer, Roche7 days agoAngus LiuBy Angus Liumore_vert
On Cancer - Memorial Sloan KetteringFDA Grants Accelerated Approval to Repotrectinib for Cancers with NTRK Fusions8 days agomore_vert
Pharmacy Practice NewsAugtyro Approved for Adult and Pediatric Patients With NTRK Gene Fusion-Positive Solid Tumors4 days agomore_vert
Verywell HealthThe FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot15 hours agoFran KritzBy Fran Kritzmore_vert
STATReadout Newsletter: Takeda, Disc Medicine, Covid-19 vaccines4 days agoMeghana KeshavanBy Meghana Keshavanmore_vert
University of Minnesota Twin CitiesFDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases7 days agoLisa SchnirringBy Lisa Schnirringmore_vert
Fox NewsCOVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement6 days agoMelissa RudyBy Melissa Rudymore_vert
The Pharma LetterFinal FDA guidance on development of oligonucleotide therapeutics5 hours agomore_vert
Fast CompanyCoffee recall 2024: botulinum toxin may be deadly, product list2 hours agoMichael GrothausBy Michael Grothausmore_vert
Food Safety NewsCanned coffee products sold under 128 coffee roaster names recalled over potential Clostridium botulinum contamination2 hours agomore_vert
DARKDaily.com - Laboratory NewsFDA Grants Marketing Authorization to First Ever AI-Powered SaMD Diagnostic Tool for Sepsis That Shares Patient's Risk within 24 Hours and Works with EHRs4 hours agomore_vert
Hindustan TimesScientifically Speaking | How AI is paving the way for antibiotic discoveryOpinion3 days agoAnirban MahapatraBy Anirban Mahapatramore_vert
PR NewswireDay Zero Diagnostics Presents Direct-From-Blood, Rapid Antimicrobial Susceptibility Testing at ASM Microbe4 days agomore_vert
Vision MondayNeurotech Pharmaceuticals Receives Priority Review of Biologics License Application From the FDA for Treatment of Retinal Disease10 hours agomore_vert
Business WireNeurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)Yesterdaymore_vert
Clinical Trials ArenaUS FDA clears Kyverna's KYV-101 cell therapy for Phase II SPS trial6 hours agomore_vertFull Coverage of this story
WQAD MolineFDA begins reviewing new medication for Alzheimer's2 hours agomore_vertFull Coverage of this story
Seeking AlphaLexicon resubmits FDA application for sotagliflozin for type 1 diabetes (NASDAQ:LXRX)1 hour agomore_vert
StockTitanLexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes3 hours agomore_vert
AFP FactcheckPosts promoting unregistered weight loss pills share altered Myanmar FDA certificate8 hours agomore_vert
Cardiovascular BusinessFDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as 'tip of the iceberg'17 hours agoMichael WalterBy Michael Waltermore_vert
Diagnostic and Interventional CardiologyElutia Announces FDA Clearance of EluPro: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators4 days agomore_vert
BioWorld OnlineFDA clears Elutia's bioenvelope to protect implanted devices4 days agoAnnette BoyleBy Annette Boylemore_vert
TipRanksAziyo Biologics Gains FDA Clearance for EluPro® Bioenvelope - TipRanks.com4 days agomore_vert
StockTitanElutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators4 days agomore_vert
USA TODAYFDA cucumber recall: Salmonella cases rise among those who ate them7 days agoMike SniderBy Mike Snidermore_vert
NewsweekCucumber Recall Map as FDA Issues Highest Alert in Four States2 days agoAlia ShoaibBy Alia Shoaibmore_vert
The News JournalSalmonella outbreak from recalled cucumbers impacts Delaware, What you should know5 days agoGreg Giesen, Maureen Groppe & Anitra JohnsonBy Greg Giesen, Maureen Groppe & Anitra Johnsonmore_vert
SelfCucumbers Linked to Salmonella Could Pose 'Serious Adverse Health Consequences or Death'4 days agomore_vert
Regulatory FocusDrugmakers, compounders at odds over FDA's difficult-to-compound rule10 hours agomore_vert
Womble Bond DickinsonFDA Updates Guidance on Intentional Genomic Alterations in Animals18 hours agomore_vert
Health ImagingPhilips's new motorized C-arm earns FDA clearance17 hours agoHannah MurphyBy Hannah Murphymore_vertFull Coverage of this story
Cancer Health Treatment NewsFDA Approves Two First-Line Immunotherapies for Endometrial Cancer15 hours agoLiz HighleymanBy Liz Highleymanmore_vert
FiercePharmaThe world's best-selling medicine adds 40th US approval3 days agoAngus LiuBy Angus Liumore_vert
FirstWord PharmaFDA nod for Keytruda sets up three-way battle in endometrial cancer3 days agomore_vert
Yahoo FinanceCovid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment3 days agomore_vert
ReutersAstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer4 days agoRadhika AnilkumarBy Radhika Anilkumarmore_vert
AboutLawsuits.comFDA Proposes Skin Reaction Label Warning for Tylenol, Other Drugs Containing Acetaminophen11 minutes agoIrvin JacksonBy Irvin Jacksonmore_vert
FOX 59 IndianapolisWHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs17 hours agomore_vert
ForbesFake Weight Loss Drugs: What To Know As Eli Lilly Plans Lawsuits Against Mounjaro, Zepbound Counterfeiters20 hours agoArianna JohnsonBy Arianna Johnsonmore_vert
World Health Organization (WHO)WHO issues warning on falsified medicines used for diabetes treatment and weight lossYesterdaymore_vert
The National Law ReviewFDA Issues Final Rule Overhauling Regulation of Medical Gases20 hours agomore_vert
FirstWord PharmaFDA unpauses Huntington's study after PTC points to positive biomarker trends21 hours agoElizabeth EatonBy Elizabeth Eatonmore_vert
BioSpacePTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical HoldYesterdayTyler PatchenBy Tyler Patchenmore_vert
Investing.comJPMorgan maintains $53 target on PTC Therapeutics stock By Investing.com20 hours agoLina GuerreroBy Lina Guerreromore_vert
StockTitanInterim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease PatientsYesterdaymore_vert
BenzingaPTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder - PTC Therapeutics (NASDAQ:PTCT)YesterdayVandana SinghBy Vandana Singhmore_vert
GlobeNewswireTonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of FibromyalgiaYesterdaymore_vertFull Coverage of this story
Everyday HealthSkyrizi (Risankizumab) for Ulcerative Colitis Gets FDA Approval11 hours agoLisa RapaportBy Lisa Rapaportmore_vert
Crain's Chicago BusinessAbbVie in 'gold rush' for treating bowel disease2 days agoJon AsplundBy Jon Asplundmore_vert
FiercePharmaAbbVie's rising star Skyrizi nabs key ulcerative colitis FDA approval23 hours agoZoey BeckerBy Zoey Beckermore_vert
PR NewswireU.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease3 days agomore_vert
FiercePharmaMerck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults4 days agoKevin DunleavyBy Kevin Dunleavymore_vert
CNBCFDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections4 days agoAnnika Kim ConstantinoBy Annika Kim Constantinomore_vert
Yahoo FinanceFDA approves Merck's pneumonia vaccine for adults3 days agoMelanie RiehlBy Melanie Riehlmore_vert
MarketWatchMerck’s vaccine approval poses threat to one of Pfizer’s top-selling products4 days agoEleanor LaiseBy Eleanor Laisemore_vert
MorningstarMCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for ImplantsYesterdaymore_vert
Marler BlogFDA, CDC and State Health Departments busy investigating Salmonella, Listeria and E. coli Outbreaks20 hours agoBill MarlerBy Bill Marlermore_vert
Food Safety NewsFederal officials investigating new outbreak of Salmonella infections11 hours agoCoral BeachBy Coral Beachmore_vert
Food Poison Journal36 with Salmonella linked to Trader Joe's BasilYesterdayWilliam MarlerBy William Marlermore_vert
Food Poisoning BulletinNew Salmonella Typhimurium Outbreak On FDA CORE Table10 hours agoLinda LarsenBy Linda Larsenmore_vert
BioPharma-Reporter.comFDA approves Biotest's YimmugoYesterdayClara Rodríguez FernándezBy Clara Rodríguez Fernándezmore_vertFull Coverage of this story
Drug Store NewsAlembic secures FDA approval for generic PradaxaYesterdaySandra LevyBy Sandra Levymore_vert
ETHealthWorldAlembic Pharmaceuticals receives US FDA approval for Dabigatran Etexilate capsules, 75 mg, 150 mg3 days agomore_vert
Indian Pharma PostAlembic Pharmaceuticals gets USFDA final approval for Dabigatran Etexilate capsules3 days agomore_vert
CBS NewsFDA "inadvertently archived" complaint about Abbott infant formula plant, audit says7 days agoKate GibsonBy Kate Gibsonmore_vert
The HillFDA took 15 months to act on infant formula whistleblower complaint, audit says4 days agoNathaniel WeixelBy Nathaniel Weixelmore_vert
Washington TimesLawmaker says watchdog's report on FDA handling of infant formula crisis confirms panel's findings4 days agoKerry PicketBy Kerry Picketmore_vert
WWMT-TVReport reveals FDA flaws in baby formula investigation, prompting new legislation7 days agoAutumn PitchureBy Autumn Pitchuremore_vert
Bloomberg LawFDA Lacked Inspection, Recall Plans in Infant Formula Shortage8 days agoNyah PhengsitthyBy Nyah Phengsitthymore_vert
BarchartDravet Syndrome Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | GW Pharma, Zogenix Inc, Stoke Therapeutics, Takeda Pharma, Supernus PharmaYesterdaymore_vert
AZ Public Health AssociationHobbs Vetoes Arizona's Magic Mushroom Bill; Signs Bill Allowing Ecstasy (Molly) if FDA Approves its Use – AZ Public Health Association2 days agomore_vert
The Arizona RepublicGovernor approves 'magic mushroom' research, Molly therapy in ArizonaYesterdayRay SternBy Ray Sternmore_vert
ABC15 Arizona in Phoenix'Magic Mushroom' bill vetoed, but human clinical testing to move forward2 days agomore_vert
Marijuana MomentArizona's Democratic Governor Vetoes Bill To Legalize Psilocybin Service Centers2 days agoKyle JaegerBy Kyle Jaegermore_vert
KJZZHobbs vetoes Arizona bill that would have allowed magic mushrooms for medial treatment23 hours agoWayne SchutskyBy Wayne Schutskymore_vert
Angioedema News TodayKalVista asks FDA to approve oral, on-demand sebetralstat for HAEYesterdaySteve BrysonBy Steve Brysonmore_vertFull Coverage of this story
Jacksonville Daily RecordCadrenal drug moving closer to FDA approval | Jax Daily RecordYesterdayMark BaschBy Mark Baschmore_vert
CNN‘What the hell are you waiting for?’ Senators grill FDA, DOJ about lack of action on youth vaping epidemic9 days agoJen ChristensenBy Jen Christensenmore_vert
FDA.govFDA Warns Six Online Retailers for Selling Unauthorized E-Liquids Resembling Prescription Drug Bottles9 days agomore_vert
ReutersU.S. health secretary backs proposed FDA crackdown on e-cigarettes: CNBCSep 14, 2018Bernadette Baum & Kanishka SinghBy Bernadette Baum & Kanishka Singhmore_vert
U.S. News & World ReportSenators Blast Health and Law Enforcement Officials Over Illegal E-Cigarettes Used by Teens9 days agomore_vert
CNBCJim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug10 days agoJulie ColemanBy Julie Colemanmore_vertFull Coverage of this story
CNNMore illnesses linked to Diamond Shruumz chocolate, cones and gummies, FDA says10 days agoNadia Kounang & Fabiana ChaparroBy Nadia Kounang & Fabiana Chaparromore_vertFull Coverage of this story
ReutersUS FDA classifies recall of Teleflex's inflatable devices as 'most serious'7 days agomore_vertFull Coverage of this story
The Pharma LetterFirst allogeneic cell therapy to receive US FDA BTD and RMAT designationsYesterdaymore_vert
HealioAURN001 receives breakthrough therapy, regenerative medicine advanced therapy designations2 days agoAnthony DefinoBy Anthony Definomore_vert
GeekWireAurion Biotech gets FDA approval to speed development of vision restoring treatment2 days agoLisa StifflerBy Lisa Stifflermore_vert
Yahoo FinanceAurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN0012 days agomore_vert
CBS NewsFDA issues warning about paralytic shellfish poisoning. Here's what to know.11 days agomore_vert
The Weather ChannelWarning On Toxic Shellfish In Eight States - Videos from The Weather Channel10 days agomore_vert
The Associated PressThings to know about FDA warning on paralytic shellfish poisoning in Pacific Northwest11 days agoClaire RushBy Claire Rushmore_vert
OregonLiveRazor clam harvest ban lifted for northern Oregon coast amid shellfish toxin scare5 days agoElliot NjusBy Elliot Njusmore_vert
NBC NewsFDA warns some oysters and clams from Pacific Northwest could be contaminated with paralytic shellfish toxins10 days agoMarlene LenthangBy Marlene Lenthangmore_vert
Pink SheetUS FDA Looking To Modernize Clinical Trial Regulations To Spur 'Evolution' In Research11 days agoSarah Karlin-SmithBy Sarah Karlin-Smithmore_vert
STATFDA seeks public input on advisory committees | STAT8 days agoMeghana KeshavanBy Meghana Keshavanmore_vert
Nature.comUnease as US drug agency weighs its use of independent scientists7 days agoMax KozlovBy Max Kozlovmore_vert
CSPI NewsroomTestimony of CSPI president, Peter Lurie, at an FDA listening session on advisory committees8 days agomore_vert
BioWorld OnlineUS FDA's Califf hints at more routine use of SGEs at advisories4 days agoMark McCartyBy Mark McCartymore_vert
ReutersUS FDA grants accelerated approval to Genfit and Ipsen's liver disease drug10 days agoPuyaan Singh & Mariam E SunnyBy Puyaan Singh & Mariam E Sunnymore_vert
MD MagazineRobert Gish, MD: Advancements in Therapeutic Development, Combination Therapy in PBC2 days agoAbigail BrooksBy Abigail Brooksmore_vert
HealioFDA approves Ipsen's Iqirvo 'to address unmet need' in primary biliary cholangitis10 days agomore_vert
BloombergIpsen, Genfit Medicine Is Cleared by FDA for Rare Liver Disorder11 days agoMarthe FourcadeBy Marthe Fourcademore_vert
USA TODAYNew COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel16 days agoEduardo CuevasBy Eduardo Cuevasmore_vert
CNBCHealthy Returns: What we know about the next round of Covid vaccines9 days agoAnnika Kim Constantino & Ashley CapootBy Annika Kim Constantino & Ashley Capootmore_vert
The Associated PressFDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines16 days agoLauran NeergaardBy Lauran Neergaardmore_vert
The Denver PostAnother COVID vaccine? Yes, and here’s why10 days agoLisa M. KriegerBy Lisa M. Kriegermore_vert
Modern GhanaFood safety: FDA implements strategy to monitor online vendors without permitsYesterdaymore_vert
GhanaWebAlarming rates of food contamination and poisoning calls for public vigilanceYesterdaymore_vert
LelezardFDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review11 minutes agomore_vert
Fox NewsFDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans8 days agoAngelica StabileBy Angelica Stabilemore_vertFull Coverage of this story
GreenStateLSD inches closer to FDA approval | GreenState22 hours agocara wietstockBy cara wietstockmore_vertFull Coverage of this story
ReutersUS FDA expands GSK's RSV vaccine approval to adults aged 50 to 5914 days agoSriparna Roy & Christy SanthoshBy Sriparna Roy & Christy Santhoshmore_vert
Investing.comModerna price target raised at Oppenheimer after RSV vaccine approval By Investing.com9 days agoVahid KaraahmetovicBy Vahid Karaahmetovicmore_vert
TipRanksGSK reports FDA approves expanded age indication for AREXVY - TipRanks.com10 days agomore_vert
StreetInsider.comModerna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'9 days agomore_vert